MIST EPS Estimates
Milestone Pharmaceuticals Inc.
$0.79
+$0.02(+2.89%)
27
Overall
--
Value
27
Tech
28
Quality
Market Cap
$98.09M
Volume
807.11K
52W Range
$0.71 - $3.06
Target Price
$5.86
MIST EPS estimates: the consensus estimate for Milestone Pharmaceuticals Inc.'s current fiscal year is -$0.84 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
MIST EPS Estimates
- EPS estimate, current quarter
- $-0.20
- EPS estimate, next quarter
- $-0.22
- EPS estimate, current year
- $-0.84
- EPS estimate, next year
- $-0.77
- EPS growth, 3-year
- +18.39%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.75 |
| 2024 | $-0.67 |
| 2023 | $-1.39 |
| 2022 | $-1.38 |
| 2021 | $-1.02 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MIST | $0.79 | +2.9% | 807.11K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Milestone Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW